Skip to main content

Medicus Pharma Ltd.

MDCX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001997296

No open-market purchases or sales by Medicus Pharma Ltd. insiders were filed in the last 90 days; 23 institutions reported holding it in 13F filings for Q2 2026, worth $1.18M in total; no superinvestor holds it.

Other share classesMDCXW

Key figures

Insider buysOpen market, last 90 days
0
Insider sellsOpen market, last 90 days
0
13F holdersQ2 2026, +2 vs. previous quarter
23
13F valueReported value at the end of Q2 2026
$1.18M
Superinvestors holdingAt the end of Q2 2026
0

Price chart

Superinvestors holding MDCX, Q2 2026

Go to the superinvestors tab

No superinvestor reported holding MDCX at the end of Q2 2026.

Latest insider trades

Open-market purchases and sales by Medicus Pharma Ltd. insiders from Form 4, newest first.

See all insider trades
Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
May 21, 2025 (view filing)12:57 PM ETMay 201 dayVelocity Fund Partners, LP and 1 other10% OwnerSSaleMedicus Pharma LTD−75.0K$7.72−$578.9K−2.3%3.25M after

Top 10 13F holders, Q2 2026

The largest institutional positions in Medicus Pharma Ltd. at the end of Q2 2026; share changes are against Q1 2026.

See all 23 holders
Institutions holding MDCX in Q2 2026
InstitutionSharesValue% of portfolioChange in sharesAction
Interchange Capital Partners, LLC1,586,871$718.4K0.14%−75,000−4.5%Reduced
Jane Street Group, LLC333,673$148.9K0.00%+333,673New
XTX Topco Ltd243,362$108.6K0.00%+243,362New
Sterling Investment Advisors, Ltd.100,000$44.6K0.01%+100,000New
Commonwealth Equity Services, LLC52,643$23.5K0.00%+4,500+9.3%Added
May Hill Capital, LLC50,622$22.6K0.00%00.0%Unchanged
Susquehanna International Group, LLP31,462$14.0K0.00%+31,462New
Stifel Financial Corp30,000$13.4K0.00%+30,000New
JPMorgan Chase & Co25,622$12.5K0.00%+25,622New
Bryn Mawr Trust Co25,622$11.4K0.00%−25,622−50.0%Reduced